Director Li Zhe of Realcan Pharmaceutical Group (002589.SZ) has been relieved of his duties pending further investigation.

12:00 13/02/2026

Ruikang Pharmaceutical (002589.SZ) announced that the company received a "Notice of Lifting the Order of Pending Investigation" issued by the Ji'yang District Supervisory Commission of Jinan City on February 13, 2026, lifting the order of pending investigation on Mr. Li Zhe (Director, Board Secretary, and Vice President of the company). Currently, the company's production and operation are normal, and Mr. Li Zhe is performing his duties normally.

Realcan Pharmaceutical Group (002589.SZ) announced that on February 13, 2026, the company received the "Notice of Lifting the Compulsory Inspection Order" issued by the Ji'nan Ji'yang District Supervisory Committee, and the compulsory inspection measures against Mr. Li Zhe (Director, Secretary of the Board of Directors, and Vice President of the Company) have been lifted. Currently, the company's production and operation are normal, and Mr. Li Zhe is performing his duties normally.

PCPD(00432) plans to sell Midtown Niseko, a Japanese eco-hotel, for 80 million US dollars.

Shenzhen Woer Heat-shrinkable Material (09981) has been included in the list of securities eligible for Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect.

SSY GROUP(02005): Propranolol hydrochloride has been approved by the Chinese drug regulatory authority as a raw material for use in marketed formulations.

PCPD(00432) plans to sell Midtown Niseko, a Japanese eco-hotel, for 80 million US dollars.

Shenzhen Woer Heat-shrinkable Material (09981) has been included in the list of securities eligible for Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect.

SSY GROUP(02005): Propranolol hydrochloride has been approved by the Chinese drug regulatory authority as a raw material for use in marketed formulations.